ELAN

Elanco Animal Health Incorporated

NYSEUSDEQUITY DELAYED

24.25

▲ 0.69 (2.93%)

MARKET · —

Price

Open

23.56

Prev close

23.56

Day high

24.15

Day low

23.69

Volume

4.75M

Market cap

—

P/E (TTM)

—

52W range

17.11 – 27.98

Trailing performance

Price return · vs SPY

Returnvs SPY

+1.27% +2.6%

-3.27% -7.0%

+12.43% +9.3%

-4.04% -15.1%

YTD

+5.92% -6.4%

+37.29% +17.3%

+107.71% +33.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

23.26

+4.26% from price

SMA 20

24.33

-1.48% from price

SMA 50

24.54

-2.32% from price

SMA 100

23.71

+2.29% from price

SMA 200

23.61

+1.54% from price

EMA 12

23.81

+1.84% from price

EMA 26

24.15

+0.42% from price

EMA 50

24.21

+0.15% from price

RSI (14)

48.7

Neutral

MACD (12,26,9)

-0.34

Hist 0.01

ATR (14)

1.24

5.17% of price

Realised vol 30D

47.2%

Annualised

Bollinger upper

27.32

20, 2σ

Bollinger lower

21.34

20, 2σ

50 / 200 cross

Golden

24.54 vs 23.61

Trend bias

Above 200

+1.54%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.36

More volatile than market

Correlation to SPY

0.41

Loosely linked

Realised vol 30D

47.2%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-26.2%

Peak to trough

Max drawdown 5Y

-76.3%

Peak to trough

ATR 14

1.24

5.17% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 24.25

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

ELAN · links out to the publisher

Director's Confidence Visible as Elanco Leader Buys 10,000 Shares Motley Fool · 3d ago 1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 We Find Risky StockStory · 5d ago 5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call StockStory · 8d ago Elanco (ELAN) Q2 2026 Earnings Call Transcript Motley Fool · 10d ago Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species ACCESS Newswire · 11d ago Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win? Simply Wall St. · 12d ago Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus Simply Wall St. · 13d ago Elanco Animal Health Q2 Earnings Call Highlights MarketBeat · 14d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.